Monoclonal antibodies binding to different epitopes of CD20 differentially sensitize DLBCL to different classes of chemotherapy is a research paper published in Frontiers in Oncology (2023). On theSindex it has a DataRank of 0.104. It has been cited 1 time.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.104
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 5R01 CA185372, T32GM008152-35
National Institute of Allergy and Infectious Diseases
Grant: AI29422, AI120701, AI138570
National Institutes of Health
Grant: 3R01AI138570-05S1
Regulation of IL10 production in CD8+ T cells during Flu infection by tyrosine kinase Itk
National Institutes of Health
Grant: 5T32GM008152-28
Medical Scientist Training Program
National Institutes of Health
Grant: 5R01AI120701-03
Itk mediated tuning of CD8+ memory T cell development
National Institutes of Health
Grant: 5R01CA185372-04
(PQD5) A novel genetic strategy to predict efficacy of anti-CD20 antibodies
FWCI
0.17
Citation Percentile
0.5%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals